Part 15 Hearing on Draft Guidances Relating to the Regulation of HCT/Ps

Part 15 Hearing on Draft Guidances Relating to the Regulation of HCT/Ps

By Center for Biologics Evaluation and Research (CBER), FDA
Sales Ended